Combined assessment using MSUS semiquantitative scores and inflammatory biomarkers may improve diagnostic accuracy and ...
HealthDay News — Higher levels of aggression in early adolescence predict more advanced biological aging by age 30 years, ...
The CDC is urging people to make sure their vaccinations are up to date, as the polio virus has been detected in several parts of the world during the past year.
The annual meeting of the AAOS highlighted recent advances in the diagnosis and management of musculoskeletal conditions.
Bimekizumab was superior to risankizumab at 16 weeks for improving PsA symptoms in a head-to-head clinical trial.
Higher SUA levels were associated with a lower risk for osteoporosis, with sex, race, diabetes status, and serum cholesterol ...
Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.
The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.
Obinutuzumab was superior to placebo for systemic lupus erythematosus in a phase 3 trial, significantly improving SRI-4 ...
The FDA accepted a New Drug Application with Priority Review for brepocitinib, an oral TYK2/JAK1 inhibitor, for the treatment ...
Testosterone replacement therapy before total knee arthroplasty was linked to higher risks for systemic and periprosthetic ...
Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ACR20 response rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results